What changed between these versions
A substantive expansion and clarification. v3 adds a new provision authorizing the disclosure of commercial information during food safety incidents and significantly modifies the destruction of refused articles section by adding explicit exceptions for certain prescription drugs and mandating regulation timelines. It also refines a conforming amendment related to information sharing.
Overview
A handful of substantive changes across three sections. · v3 expands the Secretary's authority for information disclosure, clarifies due process for article destruction, and narrows the scope of destruction orders by adding specific exceptions.
The most significant change in v3 is the addition of new authority for the Secretary to disclose commercial information during food safety incidents, aiming to enhance public health protection. Furthermore, the section on destruction of refused articles has been substantially modified to include specific timelines for regulation promulgation and to create explicit exceptions for certain prescription drugs imported for personal use. A related conforming amendment for information sharing with state and local authorities was also refined.
Major additions
This new subsection authorizes the Secretary to disclose commercial information, even if protected under 18 U.S.C. 1905, when such disclosure advances public health protection during a food safety incident. This includes outbreaks, investigations, or recalls related to contaminated food.
This addition significantly enhances the Secretary's ability to respond to food safety emergencies by removing potential barriers to sharing critical commercial data. It allows for more rapid and comprehensive communication during incidents, which could lead to faster containment of outbreaks and more effective recalls, directly impacting public health and consumer safety.
Modifications
The operative impact on the underlying Federal Food, Drug, and Cosmetic Act is the same as intended by v2: the Secretary's ability for direct accreditation of third-party auditors is removed, streamlining the accreditation process through recognized bodies. This affects entities seeking accreditation by requiring them to go through recognized accreditation bodies.
Before
v2 instructed to amend subparagraph (A) of Section 808(b)(1) to read a specific way, which implicitly removed the "direct accreditation" option for the Secretary.
After
v3 explicitly amends Section 808(b)(1)(A) by making a minor formatting change to clause (i) and explicitly striking clause (ii), which was the "direct accreditation" option.
This modification clarifies and reinforces the legal basis for the Secretary to share information with state, local, tribal, and territorial authorities as outlined in the new Section 708(d), ensuring consistency across related statutory provisions. It provides explicit statutory permission for such disclosures, which could facilitate inter-agency cooperation.
Before
v2's conforming amendment to Section 301(j) solely involved striking the second period at the end of the first sentence.
After
v3's conforming amendment to Section 301(j) includes striking the second period and also inserting specific language: "to a State, local, Tribal, or territorial authority as specified in section 708(d)," after "of the Department,".
For owners or consignees of refused articles, the due process framework is more clearly defined, and the Secretary's discretion to combine proceedings is explicitly stated. For the FDA, there are now mandated timelines for implementing regulations. Crucially, individuals importing non-controlled prescription drugs for personal use are explicitly protected from having their articles ordered for destruction under this authority, which significantly impacts consumers relying on such imports.
Before
v2 added a single paragraph to Section 801(v) authorizing the Secretary to order destruction of refused articles presenting a significant public health concern, requiring regulations for notice and due process.
After
v3 restructures Section 801(v) into four paragraphs. It retains the destruction authority but adds explicit provisions for combining due process proceedings, mandates specific timelines for issuing proposed and final regulations, and introduces exceptions for certain prescription drugs imported for personal use, clarifying they are not considered a "significant public health concern" for this section.
Scope
Meaningful expansion or narrowing — Changes are scattered across three distinct sections (Section 2, 3, and 4) of the bill, affecting different aspects of food safety regulation and enforcement. — v3 represents a meaningful refinement and expansion in some areas (information sharing) while also introducing specific limitations and procedural mandates in others (destruction of refused articles). The overall direction remains focused on enhancing food safety but with added nuance regarding privacy and individual imports. — The changes in Section 3(a) and 3(b) directly interact by creating new authority for information sharing and then updating a conforming amendment to reflect this new authority. The changes in Section 4 introduce exceptions that narrow the application of the destruction authority, affecting how "significant public health concern" is interpreted for specific articles.
Impact analysis
Secretary of Health and Human Services (FDA)
Gains authority in information sharing, procedural mandates in regulation development.
Gains new explicit authority to disclose commercial information during food safety incidents. Also faces new mandated timelines for issuing regulations regarding the destruction of refused articles.
State, local, Tribal, and territorial authorities with public health functions
Gains clearer access to information.
The legal framework for receiving unredacted food safety information from the FDA is strengthened and explicitly referenced in a conforming amendment.
Owners or consignees of refused articles (food or otherwise)
Procedural clarification.
The due process provisions for challenging a destruction order are clarified, including the explicit option for the Secretary to combine proceedings.
Individuals importing certain prescription drugs for personal or household use (non-controlled substances under section 804(j))
Gains protection from destruction orders.
Explicitly exempted from the Secretary's authority to order destruction of refused articles, and such drugs are clarified not to be a "significant public health concern" for this section.
Entities in the food supply chain whose commercial information is held by the FDA
Experiences increased risk of disclosure of commercial information under specific public health circumstances.
Their protected commercial information may now be disclosed by the Secretary during food safety incidents if it advances public health protection.